Not too long ago I blogged about dodgy antimalarials as a public health risk. Here is a disturbing news report published in The Guardian about GlaxoSmithKline (GSK) pharmaceuticals.
GSK was recently reprimanded for the promotion of anti-depressants for unapproved indications, concealing critical safety evidence from the FDA and offering lavish entertainment and incentives to doctors for endorsing their products. They were hit with a $3 billion fine, which in light of their massive profits, really will have little impact on their bottom line.
This is Big Pharma at its worst.This is a betrayal of the public's trust in medicine and science.
GSK was recently reprimanded for the promotion of anti-depressants for unapproved indications, concealing critical safety evidence from the FDA and offering lavish entertainment and incentives to doctors for endorsing their products. They were hit with a $3 billion fine, which in light of their massive profits, really will have little impact on their bottom line.
This is Big Pharma at its worst.This is a betrayal of the public's trust in medicine and science.